Summary

The global IgG4 Antibody market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
IgG4 Antibody is a subclass of the IgG antibody, one of the major classes of antibodies produced by the immune system. IgG4 antibodies are involved in immune responses by recognizing and neutralizing foreign substances such as bacteria and viruses. This subclass of IgG antibodies is known for its lower affinity for antigens compared to other IgG subclasses, which allows for broader reactivity. IgG4 are commonly used in research and diagnostic applications to study immune responses and detect the presence of certain diseases, including autoimmune diseases and cancer.
The industry trend for IgG4 Antibody has seen a rise due to its importance in immunology research and diagnostics. These antibodies have specific applications in the detection and characterization of certain diseases and conditions. The potential for IgG4 Antibody in targeted therapeutics and precision medicine is expected to drive the industry trend forward. As the field of immunology continues to advance, the use of IgG4 Antibody in research and potential clinical applications is likely to remain strong.
The global IgG4 Antibody market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Bio X Cell
SouthernBiotech
MyBioSource
BosterBio
Biorbyt
BioLegend
Novus Biologicals
Sino Biological
RevMAb Biosciences
RayBiotech
ichorbio
Absolute Antibody
AntibodySystem
Thermo Fisher Scientific
Affinity Immuno
Dianova
Southern Biotech
Leinco Technologies
Abnova Corporation
Kyinno
Cell Sciences
ProSci
Bio-Rad
United States Biological
DIMA Biotechnology
OriGene Technologies
Abeomics
Cayman Chemical
R&D Systems
Biomatik
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of IgG4 Antibody market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the IgG4 Antibody value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IgG4 Antibody Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global IgG4 Antibody Market Share by Revenue, by Region (2021-2026)
2.4 Global IgG4 Antibody Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America IgG4 Antibody Market Size and Prospective (2021-2032)
2.5.2 Europe IgG4 Antibody Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific IgG4 Antibody Market Size and Prospective (2021-2032)
2.5.4 Latin America IgG4 Antibody Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa IgG4 Antibody Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global IgG4 Antibody Historical Market Size by Type (2021-2026)
3.2 Global IgG4 Antibody Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of IgG4 Antibody
4 Breakdown Data by Application
4.1 Global IgG4 Antibody Historical Market Size by Application (2021-2026)
4.2 Global IgG4 Antibody Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in IgG4 Antibody Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top IgG4 Antibody Players by Revenue (2021-2026)
5.1.2 Global IgG4 Antibody Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by IgG4 Antibody Revenue
5.4 Global IgG4 Antibody Market Concentration Analysis
5.4.1 Global IgG4 Antibody Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by IgG4 Antibody Revenue in 2025
5.5 Global Key Players of IgG4 Antibody Head Offices and Areas Served
5.6 Global Key Players of IgG4 Antibody, Product and Application
5.7 Global Key Players of IgG4 Antibody, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America IgG4 Antibody Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America IgG4 Antibody Market Size by Type (2021-2026)
6.1.2.2 North America IgG4 Antibody Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America IgG4 Antibody Market Size by Application (2021-2026)
6.1.3.2 North America IgG4 Antibody Market Share by Application (2021-2026)
6.1.4 North America IgG4 Antibody Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe IgG4 Antibody Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe IgG4 Antibody Market Size by Type (2021-2026)
6.2.2.2 Europe IgG4 Antibody Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe IgG4 Antibody Market Size by Application (2021-2026)
6.2.3.2 Europe IgG4 Antibody Market Share by Application (2021-2026)
6.2.4 Europe IgG4 Antibody Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific IgG4 Antibody Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific IgG4 Antibody Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific IgG4 Antibody Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific IgG4 Antibody Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific IgG4 Antibody Market Share by Application (2021-2026)
6.3.4 Asia-Pacific IgG4 Antibody Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America IgG4 Antibody Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America IgG4 Antibody Market Size by Type (2021-2026)
6.4.2.2 Latin America IgG4 Antibody Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America IgG4 Antibody Market Size by Application (2021-2026)
6.4.3.2 Latin America IgG4 Antibody Market Share by Application (2021-2026)
6.4.4 Latin America IgG4 Antibody Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa IgG4 Antibody Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa IgG4 Antibody Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa IgG4 Antibody Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa IgG4 Antibody Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa IgG4 Antibody Market Share by Application (2021-2026)
6.5.4 Middle East & Africa IgG4 Antibody Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Bio X Cell
7.1.1 Bio X Cell Company Details
7.1.2 Bio X Cell Business Overview
7.1.3 Bio X Cell IgG4 Antibody Introduction
7.1.4 Bio X Cell Revenue in IgG4 Antibody Business (2021-2026)
7.1.5 Bio X Cell Recent Development
7.2 SouthernBiotech
7.2.1 SouthernBiotech Company Details
7.2.2 SouthernBiotech Business Overview
7.2.3 SouthernBiotech IgG4 Antibody Introduction
7.2.4 SouthernBiotech Revenue in IgG4 Antibody Business (2021-2026)
7.2.5 SouthernBiotech Recent Development
7.3 MyBioSource
7.3.1 MyBioSource Company Details
7.3.2 MyBioSource Business Overview
7.3.3 MyBioSource IgG4 Antibody Introduction
7.3.4 MyBioSource Revenue in IgG4 Antibody Business (2021-2026)
7.3.5 MyBioSource Recent Development
7.4 BosterBio
7.4.1 BosterBio Company Details
7.4.2 BosterBio Business Overview
7.4.3 BosterBio IgG4 Antibody Introduction
7.4.4 BosterBio Revenue in IgG4 Antibody Business (2021-2026)
7.4.5 BosterBio Recent Development
7.5 Biorbyt
7.5.1 Biorbyt Company Details
7.5.2 Biorbyt Business Overview
7.5.3 Biorbyt IgG4 Antibody Introduction
7.5.4 Biorbyt Revenue in IgG4 Antibody Business (2021-2026)
7.5.5 Biorbyt Recent Development
7.6 BioLegend
7.6.1 BioLegend Company Details
7.6.2 BioLegend Business Overview
7.6.3 BioLegend IgG4 Antibody Introduction
7.6.4 BioLegend Revenue in IgG4 Antibody Business (2021-2026)
7.6.5 BioLegend Recent Development
7.7 Novus Biologicals
7.7.1 Novus Biologicals Company Details
7.7.2 Novus Biologicals Business Overview
7.7.3 Novus Biologicals IgG4 Antibody Introduction
7.7.4 Novus Biologicals Revenue in IgG4 Antibody Business (2021-2026)
7.7.5 Novus Biologicals Recent Development
7.8 Sino Biological
7.8.1 Sino Biological Company Details
7.8.2 Sino Biological Business Overview
7.8.3 Sino Biological IgG4 Antibody Introduction
7.8.4 Sino Biological Revenue in IgG4 Antibody Business (2021-2026)
7.8.5 Sino Biological Recent Development
7.9 RevMAb Biosciences
7.9.1 RevMAb Biosciences Company Details
7.9.2 RevMAb Biosciences Business Overview
7.9.3 RevMAb Biosciences IgG4 Antibody Introduction
7.9.4 RevMAb Biosciences Revenue in IgG4 Antibody Business (2021-2026)
7.9.5 RevMAb Biosciences Recent Development
7.10 RayBiotech
7.10.1 RayBiotech Company Details
7.10.2 RayBiotech Business Overview
7.10.3 RayBiotech IgG4 Antibody Introduction
7.10.4 RayBiotech Revenue in IgG4 Antibody Business (2021-2026)
7.10.5 RayBiotech Recent Development
7.11 ichorbio
7.11.1 ichorbio Company Details
7.11.2 ichorbio Business Overview
7.11.3 ichorbio IgG4 Antibody Introduction
7.11.4 ichorbio Revenue in IgG4 Antibody Business (2021-2026)
7.11.5 ichorbio Recent Development
7.12 Absolute Antibody
7.12.1 Absolute Antibody Company Details
7.12.2 Absolute Antibody Business Overview
7.12.3 Absolute Antibody IgG4 Antibody Introduction
7.12.4 Absolute Antibody Revenue in IgG4 Antibody Business (2021-2026)
7.12.5 Absolute Antibody Recent Development
7.13 AntibodySystem
7.13.1 AntibodySystem Company Details
7.13.2 AntibodySystem Business Overview
7.13.3 AntibodySystem IgG4 Antibody Introduction
7.13.4 AntibodySystem Revenue in IgG4 Antibody Business (2021-2026)
7.13.5 AntibodySystem Recent Development
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Company Details
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific IgG4 Antibody Introduction
7.14.4 Thermo Fisher Scientific Revenue in IgG4 Antibody Business (2021-2026)
7.14.5 Thermo Fisher Scientific Recent Development
7.15 Affinity Immuno
7.15.1 Affinity Immuno Company Details
7.15.2 Affinity Immuno Business Overview
7.15.3 Affinity Immuno IgG4 Antibody Introduction
7.15.4 Affinity Immuno Revenue in IgG4 Antibody Business (2021-2026)
7.15.5 Affinity Immuno Recent Development
7.16 Dianova
7.16.1 Dianova Company Details
7.16.2 Dianova Business Overview
7.16.3 Dianova IgG4 Antibody Introduction
7.16.4 Dianova Revenue in IgG4 Antibody Business (2021-2026)
7.16.5 Dianova Recent Development
7.17 Southern Biotech
7.17.1 Southern Biotech Company Details
7.17.2 Southern Biotech Business Overview
7.17.3 Southern Biotech IgG4 Antibody Introduction
7.17.4 Southern Biotech Revenue in IgG4 Antibody Business (2021-2026)
7.17.5 Southern Biotech Recent Development
7.18 Leinco Technologies
7.18.1 Leinco Technologies Company Details
7.18.2 Leinco Technologies Business Overview
7.18.3 Leinco Technologies IgG4 Antibody Introduction
7.18.4 Leinco Technologies Revenue in IgG4 Antibody Business (2021-2026)
7.18.5 Leinco Technologies Recent Development
7.19 Abnova Corporation
7.19.1 Abnova Corporation Company Details
7.19.2 Abnova Corporation Business Overview
7.19.3 Abnova Corporation IgG4 Antibody Introduction
7.19.4 Abnova Corporation Revenue in IgG4 Antibody Business (2021-2026)
7.19.5 Abnova Corporation Recent Development
7.20 Kyinno
7.20.1 Kyinno Company Details
7.20.2 Kyinno Business Overview
7.20.3 Kyinno IgG4 Antibody Introduction
7.20.4 Kyinno Revenue in IgG4 Antibody Business (2021-2026)
7.20.5 Kyinno Recent Development
7.21 Cell Sciences
7.21.1 Cell Sciences Company Details
7.21.2 Cell Sciences Business Overview
7.21.3 Cell Sciences IgG4 Antibody Introduction
7.21.4 Cell Sciences Revenue in IgG4 Antibody Business (2021-2026)
7.21.5 Cell Sciences Recent Development
7.22 ProSci
7.22.1 ProSci Company Details
7.22.2 ProSci Business Overview
7.22.3 ProSci IgG4 Antibody Introduction
7.22.4 ProSci Revenue in IgG4 Antibody Business (2021-2026)
7.22.5 ProSci Recent Development
7.23 Bio-Rad
7.23.1 Bio-Rad Company Details
7.23.2 Bio-Rad Business Overview
7.23.3 Bio-Rad IgG4 Antibody Introduction
7.23.4 Bio-Rad Revenue in IgG4 Antibody Business (2021-2026)
7.23.5 Bio-Rad Recent Development
7.24 United States Biological
7.24.1 United States Biological Company Details
7.24.2 United States Biological Business Overview
7.24.3 United States Biological IgG4 Antibody Introduction
7.24.4 United States Biological Revenue in IgG4 Antibody Business (2021-2026)
7.24.5 United States Biological Recent Development
7.25 DIMA Biotechnology
7.25.1 DIMA Biotechnology Company Details
7.25.2 DIMA Biotechnology Business Overview
7.25.3 DIMA Biotechnology IgG4 Antibody Introduction
7.25.4 DIMA Biotechnology Revenue in IgG4 Antibody Business (2021-2026)
7.25.5 DIMA Biotechnology Recent Development
7.26 OriGene Technologies
7.26.1 OriGene Technologies Company Details
7.26.2 OriGene Technologies Business Overview
7.26.3 OriGene Technologies IgG4 Antibody Introduction
7.26.4 OriGene Technologies Revenue in IgG4 Antibody Business (2021-2026)
7.26.5 OriGene Technologies Recent Development
7.27 Abeomics
7.27.1 Abeomics Company Details
7.27.2 Abeomics Business Overview
7.27.3 Abeomics IgG4 Antibody Introduction
7.27.4 Abeomics Revenue in IgG4 Antibody Business (2021-2026)
7.27.5 Abeomics Recent Development
7.28 Cayman Chemical
7.28.1 Cayman Chemical Company Details
7.28.2 Cayman Chemical Business Overview
7.28.3 Cayman Chemical IgG4 Antibody Introduction
7.28.4 Cayman Chemical Revenue in IgG4 Antibody Business (2021-2026)
7.28.5 Cayman Chemical Recent Development
7.29 R&D Systems
7.29.1 R&D Systems Company Details
7.29.2 R&D Systems Business Overview
7.29.3 R&D Systems IgG4 Antibody Introduction
7.29.4 R&D Systems Revenue in IgG4 Antibody Business (2021-2026)
7.29.5 R&D Systems Recent Development
7.30 Biomatik
7.30.1 Biomatik Company Details
7.30.2 Biomatik Business Overview
7.30.3 Biomatik IgG4 Antibody Introduction
7.30.4 Biomatik Revenue in IgG4 Antibody Business (2021-2026)
7.30.5 Biomatik Recent Development
8 IgG4 Antibody Market Dynamics
8.1 IgG4 Antibody Industry Trends
8.2 IgG4 Antibody Market Drivers
8.3 IgG4 Antibody Market Challenges
8.4 IgG4 Antibody Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global IgG4 Antibody Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global IgG4 Antibody Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market IgG4 Antibody Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global IgG4 Antibody Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global IgG4 Antibody Revenue Share by Region (2021-2026)
Table 6. Global IgG4 Antibody Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global IgG4 Antibody Revenue Share Forecast by Region (2027-2032)
Table 8. Global IgG4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global IgG4 Antibody Market Share by Revenue, by Type (2021-2026)
Table 10. Global IgG4 Antibody Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global IgG4 Antibody Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global IgG4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global IgG4 Antibody Market Share by Revenue, by Application (2021-2026)
Table 15. Global IgG4 Antibody Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global IgG4 Antibody Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in IgG4 Antibody Applications
Table 18. Global IgG4 Antibody Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global IgG4 Antibody Market Share by Players (2021-2026)
Table 20. Global Top IgG4 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG4 Antibody as of 2025)
Table 21. Ranking of Global Top IgG4 Antibody Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by IgG4 Antibody Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of IgG4 Antibody, Headquarters and Area Served
Table 24. Global Key Players of IgG4 Antibody, Product and Application
Table 25. Global Key Players of IgG4 Antibody, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America IgG4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America IgG4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 29. North America IgG4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America IgG4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe IgG4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe IgG4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 33. Europe IgG4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe IgG4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific IgG4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific IgG4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific IgG4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific IgG4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America IgG4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America IgG4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America IgG4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America IgG4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa IgG4 Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa IgG4 Antibody Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa IgG4 Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa IgG4 Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 47. Bio X Cell Company Details
Table 48. Bio X Cell Business Overview
Table 49. Bio X Cell IgG4 Antibody Product
Table 50. Bio X Cell Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 51. Bio X Cell Recent Development
Table 52. SouthernBiotech Company Details
Table 53. SouthernBiotech Business Overview
Table 54. SouthernBiotech IgG4 Antibody Product
Table 55. SouthernBiotech Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 56. SouthernBiotech Recent Development
Table 57. MyBioSource Company Details
Table 58. MyBioSource Business Overview
Table 59. MyBioSource IgG4 Antibody Product
Table 60. MyBioSource Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 61. MyBioSource Recent Development
Table 62. BosterBio Company Details
Table 63. BosterBio Business Overview
Table 64. BosterBio IgG4 Antibody Product
Table 65. BosterBio Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 66. BosterBio Recent Development
Table 67. Biorbyt Company Details
Table 68. Biorbyt Business Overview
Table 69. Biorbyt IgG4 Antibody Product
Table 70. Biorbyt Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 71. Biorbyt Recent Development
Table 72. BioLegend Company Details
Table 73. BioLegend Business Overview
Table 74. BioLegend IgG4 Antibody Product
Table 75. BioLegend Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 76. BioLegend Recent Development
Table 77. Novus Biologicals Company Details
Table 78. Novus Biologicals Business Overview
Table 79. Novus Biologicals IgG4 Antibody Product
Table 80. Novus Biologicals Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 81. Novus Biologicals Recent Development
Table 82. Sino Biological Company Details
Table 83. Sino Biological Business Overview
Table 84. Sino Biological IgG4 Antibody Product
Table 85. Sino Biological Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 86. Sino Biological Recent Development
Table 87. RevMAb Biosciences Company Details
Table 88. RevMAb Biosciences Business Overview
Table 89. RevMAb Biosciences IgG4 Antibody Product
Table 90. RevMAb Biosciences Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 91. RevMAb Biosciences Recent Development
Table 92. RayBiotech Company Details
Table 93. RayBiotech Business Overview
Table 94. RayBiotech IgG4 Antibody Product
Table 95. RayBiotech Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 96. RayBiotech Recent Development
Table 97. ichorbio Company Details
Table 98. ichorbio Business Overview
Table 99. ichorbio IgG4 Antibody Product
Table 100. ichorbio Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 101. ichorbio Recent Development
Table 102. Absolute Antibody Company Details
Table 103. Absolute Antibody Business Overview
Table 104. Absolute Antibody IgG4 Antibody Product
Table 105. Absolute Antibody Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 106. Absolute Antibody Recent Development
Table 107. AntibodySystem Company Details
Table 108. AntibodySystem Business Overview
Table 109. AntibodySystem IgG4 Antibody Product
Table 110. AntibodySystem Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 111. AntibodySystem Recent Development
Table 112. Thermo Fisher Scientific Company Details
Table 113. Thermo Fisher Scientific Business Overview
Table 114. Thermo Fisher Scientific IgG4 Antibody Product
Table 115. Thermo Fisher Scientific Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 116. Thermo Fisher Scientific Recent Development
Table 117. Affinity Immuno Company Details
Table 118. Affinity Immuno Business Overview
Table 119. Affinity Immuno IgG4 Antibody Product
Table 120. Affinity Immuno Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 121. Affinity Immuno Recent Development
Table 122. Dianova Company Details
Table 123. Dianova Business Overview
Table 124. Dianova IgG4 Antibody Product
Table 125. Dianova Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 126. Dianova Recent Development
Table 127. Southern Biotech Company Details
Table 128. Southern Biotech Business Overview
Table 129. Southern Biotech IgG4 Antibody Product
Table 130. Southern Biotech Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 131. Southern Biotech Recent Development
Table 132. Leinco Technologies Company Details
Table 133. Leinco Technologies Business Overview
Table 134. Leinco Technologies IgG4 Antibody Product
Table 135. Leinco Technologies Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 136. Leinco Technologies Recent Development
Table 137. Abnova Corporation Company Details
Table 138. Abnova Corporation Business Overview
Table 139. Abnova Corporation IgG4 Antibody Product
Table 140. Abnova Corporation Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 141. Abnova Corporation Recent Development
Table 142. Kyinno Company Details
Table 143. Kyinno Business Overview
Table 144. Kyinno IgG4 Antibody Product
Table 145. Kyinno Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 146. Kyinno Recent Development
Table 147. Cell Sciences Company Details
Table 148. Cell Sciences Business Overview
Table 149. Cell Sciences IgG4 Antibody Product
Table 150. Cell Sciences Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 151. Cell Sciences Recent Development
Table 152. ProSci Company Details
Table 153. ProSci Business Overview
Table 154. ProSci IgG4 Antibody Product
Table 155. ProSci Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 156. ProSci Recent Development
Table 157. Bio-Rad Company Details
Table 158. Bio-Rad Business Overview
Table 159. Bio-Rad IgG4 Antibody Product
Table 160. Bio-Rad Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 161. Bio-Rad Recent Development
Table 162. United States Biological Company Details
Table 163. United States Biological Business Overview
Table 164. United States Biological IgG4 Antibody Product
Table 165. United States Biological Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 166. United States Biological Recent Development
Table 167. DIMA Biotechnology Company Details
Table 168. DIMA Biotechnology Business Overview
Table 169. DIMA Biotechnology IgG4 Antibody Product
Table 170. DIMA Biotechnology Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 171. DIMA Biotechnology Recent Development
Table 172. OriGene Technologies Company Details
Table 173. OriGene Technologies Business Overview
Table 174. OriGene Technologies IgG4 Antibody Product
Table 175. OriGene Technologies Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 176. OriGene Technologies Recent Development
Table 177. Abeomics Company Details
Table 178. Abeomics Business Overview
Table 179. Abeomics IgG4 Antibody Product
Table 180. Abeomics Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 181. Abeomics Recent Development
Table 182. Cayman Chemical Company Details
Table 183. Cayman Chemical Business Overview
Table 184. Cayman Chemical IgG4 Antibody Product
Table 185. Cayman Chemical Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 186. Cayman Chemical Recent Development
Table 187. R&D Systems Company Details
Table 188. R&D Systems Business Overview
Table 189. R&D Systems IgG4 Antibody Product
Table 190. R&D Systems Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 191. R&D Systems Recent Development
Table 192. Biomatik Company Details
Table 193. Biomatik Business Overview
Table 194. Biomatik IgG4 Antibody Product
Table 195. Biomatik Revenue in IgG4 Antibody Business (2021-2026) & (US$ Million)
Table 196. Biomatik Recent Development
Table 197. IgG4 Antibody Market Trends
Table 198. IgG4 Antibody Market Drivers
Table 199. IgG4 Antibody Market Challenges
Table 200. IgG4 Antibody Market Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources


List of Figures
Figure 1. IgG4 Antibody Product Picture
Figure 2. Global IgG4 Antibody Market Share by Type: 2025 vs 2032
Figure 3. Monoclonal Antibody Features
Figure 4. Polyclonal Antibody Features
Figure 5. Global IgG4 Antibody Market Share by Application: 2025 vs 2032
Figure 6. Biotechnology
Figure 7. Medical
Figure 8. University
Figure 9. Others
Figure 10. IgG4 Antibody Report Years Considered
Figure 11. Global IgG4 Antibody Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global IgG4 Antibody Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global IgG4 Antibody Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America IgG4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe IgG4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Asia-Pacific IgG4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Latin America IgG4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Middle East & Africa IgG4 Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global IgG4 Antibody Market Share by Players in 2025
Figure 20. Global Top IgG4 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG4 Antibody as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by IgG4 Antibody Revenue in 2025
Figure 22. North America IgG4 Antibody Market Share by Type (2021-2026)
Figure 23. North America IgG4 Antibody Market Share by Application (2021-2026)
Figure 24. Europe IgG4 Antibody Market Share by Type (2021-2026)
Figure 25. Europe IgG4 Antibody Market Share by Application (2021-2026)
Figure 26. Asia-Pacific IgG4 Antibody Market Share by Type (2021-2026)
Figure 27. Asia-Pacific IgG4 Antibody Market Share by Application (2021-2026)
Figure 28. Latin America IgG4 Antibody Market Share by Type (2021-2026)
Figure 29. Latin America IgG4 Antibody Market Share by Application (2021-2026)
Figure 30. Middle East & Africa IgG4 Antibody Market Share by Type (2021-2026)
Figure 31. Middle East & Africa IgG4 Antibody Market Share by Application (2021-2026)
Figure 32. Bio X Cell Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 33. SouthernBiotech Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 34. MyBioSource Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 35. BosterBio Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 36. Biorbyt Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 37. BioLegend Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 38. Novus Biologicals Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 39. Sino Biological Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 40. RevMAb Biosciences Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 41. RayBiotech Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 42. ichorbio Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 43. Absolute Antibody Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 44. AntibodySystem Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 46. Affinity Immuno Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 47. Dianova Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 48. Southern Biotech Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 49. Leinco Technologies Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 50. Abnova Corporation Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 51. Kyinno Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 52. Cell Sciences Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 53. ProSci Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 54. Bio-Rad Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 55. United States Biological Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 56. DIMA Biotechnology Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 57. OriGene Technologies Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 58. Abeomics Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 59. Cayman Chemical Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 60. R&D Systems Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 61. Biomatik Revenue Growth Rate in IgG4 Antibody Business (2021-2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed